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Foxm1b, HFH-11B, Trident, Win, or MPP2) is expressed in multiple cell types and plays important roles in
cellular proliferation, differentiation and tumorigenesis. Genetic deletion of Foxm1 from mouse respiratory
epithelium during initial stages of lung development inhibits lung maturation and causes respiratory failure
after birth. However, the role of Foxm1 during postnatal lung morphogenesis remains unknown. In the
present study, Foxm1 expression was detected in epithelial cells of conducting and peripheral airways and
changing dynamically with lung maturation. To discern the biological role of Foxm1 in the prenatal and
postnatal lung, a novel transgenic mouse line that expresses a constitutively active form of FoxM1 (FoxM1 N-
terminal deletion mutant or FoxM1-ΔN) under the control of lung epithelial-speciﬁc SPC promoter was
produced. Expression of the FoxM1-ΔN transgene during embryogenesis caused epithelial hyperplasia,
inhibited lung sacculation and expression of the type II epithelial marker, pro-SPC. Expression of FoxM1-ΔN
mutant during the postnatal period did not inﬂuence alveologenesis but caused focal airway hyperplasia and
increased proliferation of Clara cells. Likewise, expression of FoxM1-ΔN mutant in conducting airways with
Scgb1a1 promoter was sufﬁcient to induce Clara cell hyperplasia. Furthermore, FoxM1-ΔN cooperated with
activated K-Ras to induce lung tumor growth in vivo. Increased activity of Foxm1 altered lung sacculation,
induced proliferation in the respiratory epithelium and accelerated lung tumor growth, indicating that precise
regulation of Foxm1 is critical for normal lung morphogenesis and development of lung cancer.iology, Cincinnati Children's
7009, Cincinnati, OH 45229,
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Transcription factor Forkhead Box m1 (Foxm1, previously known
as HFH-11B, Trident, Win, or MPP2) plays important roles in cellular
proliferation and differentiation during embryogenesis and develop-
ment of cancer (Costa et al., 2003; Krupczak-Hollis et al., 2004;
Laoukili et al., 2007; Ramakrishna et al., 2007; Teh et al., 2002; Ueno et
al., 2008). Foxm1 is expressed in various embryonic cell types and its
expression is dramatically increased in tumor cells during progression
of liver, lung, colon, breast and prostate cancers (Kalin et al., 2006;
Kalinichenko et al., 2004; Kim et al., 2006;Wonsey and Follettie, 2005;
Yoshida et al., 2007). Activation of Ras/Raf/MAPK (ERK) signaling
pathway drives cell cycle progression by increasing expression of
cyclin proteins that bind to cyclin-dependent kinases (CDKs)(Massague, 2004). CDK-cyclin complexes and ERK phosphorylate
the Foxm1 protein and increase its transcriptional activity by
facilitating the binding of Foxm1 with CBP co-activator protein (Ma
et al., 2005; Major et al., 2004). Foxm1 directly induces transcription
of cell cycle regulatory genes essential for G1/S and G2/M progression
(Costa, 2005; Laoukili et al., 2007; Wang et al., 2005). Hypoxia-
Inducible Factor 1 (HIF1) (Xia et al., 2009) and c-Myc (Blanco-Bose
et al., 2008) have been shown to induce Foxm1 expression, promoting
cell transformation and entry into the cell cycle.
In our previous studies we demonstrated that Foxm1−/− mice die
in utero between embryonic days 13.5 (E13.5) and E16.5 due to
structural abnormalities in development of liver, lung, and heart
(Krupczak-Hollis et al., 2004). Foxm1 deﬁciency in hepatoblasts and
cardiomyocytes was associated with accumulation of polyploid
phenotype, resulting from diminished DNA replication and failure to
progress through mitosis (Korver et al., 1998; Krupczak-Hollis et al.,
2004; Ramakrishna et al., 2007). Foxm1−/− livers failed to form
intrahepatic bile ducts, indicating that Foxm1 is required for
differentiation of hepatoblast precursor cells toward the biliary
epithelial cell lineage (Krupczak-Hollis et al., 2004). Foxm1−/−
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chyme into mature capillary endothelial cells during the canalicular
stage of lung development (Kim et al., 2005). Conditional deletion of
Foxm1 from precursors of cerebellar granule neurons delayed brain
development due to decreased Shh-induced proliferation (Schuller
et al., 2007). Severe abnormalities in postnatal β-cell mass
expansion were observed in Foxm1-deleted pancreatic cells, causing
impaired islet function and early onset of diabetes in mouse (Zhang
et al., 2006). Foxm1 deﬁciency in smooth muscle cells was
associated with perinatal lethality due to severe pulmonary
hemorrhage, and structural abnormalities in arterial walls and
esophagus (Ustiyan et al., 2009). These studies demonstrated that
Foxm1 plays distinct roles in differentiation and proliferation in
various tissues during embryogenesis.
We recently generated mice with an inducible deletion of Foxm1
from respiratory epithelium (SPC-rtTA/TetO-Cre/Foxm1ﬂ/ﬂ mice).
Foxm1 inactivation in undifferentiated epithelial cells prior to the
initiation of lung development did not affect branching lung
morphogenesis but impaired lung maturation and decreased surfac-
tant production, causing respiratory failure after birth (Kalin et al.,
2008). However, this mouse model did not allow us to determine the
role of Foxm1 in fully differentiated epithelial cells due to incomplete
Foxm1 deletion in the late gestation and the postnatal period.
Furthermore, given the importance of Foxm1 in the development of
non-small cell lung cancer in mice and humans (Kim et al., 2006;
Wang et al., 2009, 2008b; Yang et al., 2009), it is not clear whether
activation of Foxm1 in epithelial cells is sufﬁcient to induce lung
tumors in the adult mice. To address these issues, we developed a new
mouse model, expressing activated mutant FoxM1 protein in
respiratory epithelial cells during different periods in the embryonic
and postnatal lung.
The N-terminal region (1–232 amino acid residues) of human
FoxM1 contains a transcription inhibitory domain as well as protein
destruction box (D-box) and KEN box motifs that are required for
degradation of the FoxM1 protein (Laoukili et al., 2008; Park et al.,
2008a,b). Compared to full length FoxM1 protein, FoxM1 N-terminal
deletion mutant protein (FoxM1-ΔN) displayed increased protein
stability and transcriptional activity (Laoukili et al., 2008; Park et al.,
2008a), causing an increase of anchorage-independent cellular
proliferation in U2OS cells (Park et al., 2008a; Wang et al., 2008a). In
this study, transgenic mice expressing FoxM1-ΔN under the control of
lung epithelial-speciﬁc SPC or Scgb1a1 (Clara Cell Secretory Protein or
CCSP) promoters were generated and used to induce Foxm1 function
during different periods of embryonic andpostnatal lung development.
Material and methods
Construction of TetO-CMV-GFP-FoxM1 plasmid and generation of
transgenic mice
The expression vector of GFP-fused human FoxM1b N-terminal
deletion mutant (lacking amino acids 1–231) was obtained from Dr.
Raychuadhuri (University of Illinois at Chicago) (Park et al., 2008b).
GFP-FoxM1b N-terminal deletion mutant (GFP-FoxM1-ΔN) was
subcloned into a plasmid containing minimal CMV promoter with a
tetracycline operator (TetO7-CMV), and the 3′-untranslated region of
the bovine growth hormone (bGH) gene polyadenylation (polyA)
signal (Clark et al., 2001; Gossen et al., 1995) (Fig. 1C). The DNA
fragment containing the (TetO)7-CMV-GFP-FoxM1-ΔN (amino acids
232–748) and polyA was isolated and microinjected into mouse
oocytes at the Transgenic Mouse Facility of Cincinnati Children's
Hospital Medical Center. Three TetO-GFP-FoxM1-ΔN transgenic
mouse lines were established and showed similar phenotypes.
Transgenic mice were bred with either SPC-rtTA (line 1) or CCSP-
rtTA transgenic mice (line 2) (Chen et al., 2009; Perl et al., 2002) to
generate double transgenic mice. Single transgenic mice and wild-type littermates were used as controls. Additional controls included
double transgenic mice without Doxycycline (Dox) treatment. PCR
analysis was used to screen for the TetO-GFP-FoxM1-ΔN transgene
with sense primer made to GFP sequence: 5′-CGACAAGCAGAA-
GAACGGCATC-3′ and anti-sense primer annealed to human FoxM1b
DNA binding domain: 5′-AGTAGGGAAAGTGGTCCTCAATCC-3′. Ampli-
ﬁcation of PCR product for TetO-GFP-FoxM1-ΔN transgene was
performed by denaturation at 94 °C for 3 min and then 35 cycles of
ampliﬁcation at 94 °C for 30 s, 55 °C for 45 s, and 72 °C for 45 s, with
7 min extension at 72 °C, followed by an agarose gel electrophoresis.
PCR analysis and primers used for identiﬁcation of SPC-rtTA and CCSP-
rtTA transgenes were described previously (Liu et al., 2002; Tichelaar
et al., 2000). TetO-K-Ras transgenicmice and Rosa26-loxP-STOP-loxP-
β-galactosidase reporter mice (Rosa26R) were purchased from
Jackson Lab.
Animal use and administration of Doxycycline
Mice weremaintained in a pathogen-free vivarium in ﬁltered cages
at the animal facility of Cincinnati Children's Hospital Medical Center.
Oral Doxycycline (Dox) was given in mouse chow. Because of the light
sensitivity of Dox, Dox-containing mouse chow was replaced once a
week. Sentinelmicewere free of commonviral andbacterial pathogens.
Blood was collected from the mouse tail vein and analyzed using
Hemavet 950FS hematology analyzer (Drew Scientiﬁc Inc, Dallas, TX).
Lung total RNA isolation and real-time qRT-PCR
Mouse lung tissue was homogenized in RNA Stat-60 (Tel-Test “B”
Inc), and RNA was isolated following the manufacturer's speciﬁca-
tions. RNA was treated with DNase and puriﬁed for cDNA synthesis as
described previously (Kalinichenko et al., 2003; Wang et al., 2008b).
cDNA samples were ampliﬁed with inventoried TaqMan Gene
Expression Assays (Table 1) and analyzed by a StepOnePlus Real-
Time PCR system (Applied Biosystems). Reactions were analyzed in
triplicates and expression levels were normalized to β-actin mRNA
levels and presented as means±SD.
Dual luciferase assays for analysis of promoter activity
Human osteosarcoma U2OS cells were plated at 8×104 cells per
well in a 12-well plate and used for cotransfection experiments with
Lipofectamine 2000 (Invitrogen). The following plasmids were used:
CMV-rtTA (Tet-ON), CMV-tTA (Tet-OFF), TetO-GFP-FoxM1-ΔN, and
CDX2 promoter ﬁreﬂy-luciferase (6xCDX2-Luc) (Wang et al., 2008a;
Ye et al., 1997). Twenty-four hours after transfection, cells were
treated with 1 μg/ml of Dox (Catalog# 631311, BD Biosciences) and
incubated for an additional 24 h. Cells were harvested 48 h after
transfection and cell extracts were isolated and subjected to dual
luciferase assays (Promega). Fireﬂy luciferase activity was normalized
to Renilla luciferase activity as described (Wang et al., 2009, 2008b).
Experiments were performed in triplicate.
Lung histology, immunohistochemistry and co-localization experiments
Embryonic and adult mouse lungs were isolated, ﬁxed in 4%
paraformaldehyde, and parafﬁn-embedded. Five-micrometer-thick
lung sections were stained with hematoxylin and eosin (H&E) for
morphological examination or used for immunohistochemistry (IHC)
as described previously (Wang et al., 2009). Following antibodies
were used for IHC: transgenic FoxM1 (1:2000; H-300), endogenous
Foxm1 (1:1000; K-19) and CC10 (1:2000; T-18) were from Santa Cruz
Biotechnology. Pro-SPC (1:500; guinea pig polyclonal), FoxJ1 (1:2000;
mouse monoclonal; #3-19), TTF-1 (1:1500; mouse monoclonal;
#8G7G3-1), Sox2 (1:2500; rabbit polyclonal, WRAB-SOX2), and
FoxA2 (1:2000; rabbit polyclonal; #WRAB-FOXA2) were from Seven
Fig. 1. Foxm1 expression in mouse lungs. (A) qRT-PCR revealed changes in endogenous Foxm1 mRNA levels throughout lung development. Lungs were isolated from wild type
FVB/N mice at different stages of embryogenesis (E11–P30). The highest Foxm1 mRNA expression level (E11) was set as 1. (B) Immunohistochemistry of parafﬁn slides with
Foxm1 antibody shows endogenous Foxm1 protein (dark brown) in alveolar and bronchial regions of E15, E18 and P7 lungs. Foxm1 protein was undetectable in P30 lungs. (C) A
schematic representation of (TetO)7-GFP-FoxM1b(ΔN)-bGH polyA construct (TetO-GFP-FoxM1-ΔN). PCR primers for detection of TetO-FoxM1-ΔN transgene are shown by red
arrows. U2OS cells were transfected with CMV-rtTA and TetO-GFP-FoxM1-ΔN vectors followed by Dox treatment (Tet-ON system), or co-transfected with CMV-tTA and TetO-
GFP-FoxM1-ΔN vectors (Tet-OFF system). Nuclear GFP ﬂuorescence demonstrated that GFP-FoxM1-ΔN fusion protein was speciﬁcally induced by Dox and localized in the nuclei
of transfected cells. (D) U2OS cells were cotransfected with the TetO-GFP-FoxM1-ΔN and CMV-rtTA (Tet-ON) plasmids as well as 6xCDX2-Luciferase and CMV-Renilla luciferase
reporters. CMV-Renilla luciferase was used as internal control. Cell extracts were assayed for luciferase activity, which is presented as fold induction±SD (* indicates statistically
signiﬁcant changes, Pb0.05).
303I.-C. Wang et al. / Developmental Biology 347 (2010) 301–314
Table 1
TaqMan gene expression assays (Applied Biosystems) used for qRT-PCR.
Human primer
FoxM1 Hs00153543_m1
Mouse primers
Sox2 Mm00488369_s1
Sox4 Mm00486320_s1
Sox9 Mm00448840_m1
Sox17 Mm00488363_m1
c-Myc Mm00487804_m1
TTF1 Mm00447558_m1
CDKN1A Mm01303209_m1
PECAM1 Mm00476702_m1
α-SMA Mm00725412_s1
Foxm1 Mm00514924_m1
FoxA2 Mm00839704_mH
FoxA3 Mm00484714_m1
FoxF1a Mm00487497_m1
FoxF2 Mm00515793_m1
FoxJ1 Mm00807215_m1
FoxL1 Mm00514937_s1
FoxP1 Mm00474845_m1
FoxP2 Mm00475030_m1
β-Actin Mm00607939_s1
304 I.-C. Wang et al. / Developmental Biology 347 (2010) 301–314Hills Bioreagents (Cincinnati, OH) (Dave et al., 2008). Other antibodies
used were: Ki-67 (1:1000; rat monoclonal; #TEC-3; DAKO); β-tubulin
(1:5000; #T7451; Sigma), phospho-Histone H3 (1:2000; rabbit
polyclonal; #06-570; Millipore), Sox9 (1:1000; rabbit polyclonal;
#AB5535; Millipore), F4/80 (1:100; rat monoclonal; #MCA497GA;
AbD Serotec), α-smooth muscle actin (1:15,000; mouse monoclonal;
clone 1A4; Sigma), and PECAM-1 (1:50,000; rat monoclonal;
#553370; Pharmingen). Tumor areas in H&E-stained lung sections
were measured using the scaling function in Axiovision Rel software.
For co-localization experiments, secondary antibodies conjugated
with either Texas-Red or FITC were used, and slides were counter-
stained with DAPI (Vector Lab). Fluorescence was detected using a
Zeiss Axioplan 2 Imaging Universal Microscope with an Axiocam
MRm digital camera (Axiovision Release 4.3).
Lineage-tracing experiments and X-gal staining
SPC-rtTA/TetO-GFP-FoxM1-ΔN double transgenic mice (epFoxM1)
were bred with TetO-Cre/Rosa26-loxP-STOP-loxP-LacZ (Rosa26R)
mice to generate SPC-rtTA/TetO-GFP-FoxM1-ΔN/TetO-Cre/Rosa26R
quadruple transgenic mice. Dox was given from postnatal days 3 (P3)
to P30, causing simultaneous FoxM1-ΔN expression and Cre-
mediated excision of the LoxP-STOP-LoxP cassette from the
ROSA26 locus. SPC-rtTA/TetO-Cre/Rosa26R littermates were used as
controls. Lungs were ﬁxed and stained for β-galactosidase (β-gal)
activity as described (Bell et al., 2008). Parafﬁn sections were
counterstained with nuclear fast red.
Statistical analysis
Student's t test was used to calculate P values. Statistically
signiﬁcant changes (P valuesb0.05) were indicated with asterisks.
Results
Foxm1 expression during lung development
To examine Foxm1 expression during embryonic and postnatal
lung development, lungs were harvested fromwild type (WT)mice at
embryonic days E11–E18 or postnatal days P1–P30. Total lung RNA
was isolated and then used for quantitative real-time RT-PCR (qRT-PCR). Foxm1 mRNA levels were normalized to β-actin mRNA. The
highest Foxm1 mRNA levels were observed at E11, and Foxm1 mRNA
gradually decreased prior to birth (Fig. 1A). Consistent with previous
in situ hybridization studies (Kalin et al., 2008), Foxm1 protein was
detected in bronchial and alveolar epithelial cells, and pulmonary
mesenchyme as demonstrated by immunostaining with Foxm1
antibodies (Fig. 1B). Foxm1 expression was re-activated during the
early postnatal period (P5–P7), being increased 4–6 fold compared to
the day of birth (P1) (Fig. 1A). Foxm1 mRNA levels were further
decreased to the lowest level at P30 (Fig. 1A), consistent with
undetectable Foxm1 staining in adult lungs (Fig. 1B).
Conditional expression of activated FoxM1 mutant protein in
respiratory epithelium
Since our results showed a signiﬁcant decrease in Foxm1
expression during late gestation (Fig. 1A–B), we next performed
experiments to determine whether the reduction in Foxm1 activity
during this period is critical for normal lung development. We
generated a transgenic construct containing an activated form of the
human FoxM1 protein (FoxM1 N-terminal deletion mutant). The
FoxM1 N-terminal region (1–232 amino acids) contains a transcrip-
tion inhibitory domain as well as protein destruction box (D-box) and
KEN box motifs that are required for FoxM1 protein degradation
(Laoukili et al., 2008; Park et al., 2008a,b). FoxM1 N-terminal deletion
mutant lacking D-box and KEN-box (FoxM1-ΔN) displayed increased
protein stability when compared to the full length FoxM1 protein
(Laoukili et al., 2008; Park et al., 2008a). To generate an inducible
FoxM1-ΔN transgene, we fused the TetO7-CMV promoter region
(Clark et al., 2001) to the 5′ end of GFP-Tagged human FoxM1-ΔN
cDNA that was adjacent to a bovine growth hormone (bGH) gene
polyadenylation (polyA) signal (Fig. 1C). To determine transcriptional
activity of the TetO-GFP-FoxM1-ΔN transgenic construct, transient
cotransfection experiments were performed in U2OS cells using CMV
vectors expressing either the tetracycline transactivator (tTA; Tet-OFF
system) or tetracycline reverse transactivator (rtTA; Tet-ON system).
Twenty-four hours after transfection, cells were treated with Dox for
an additional 24 h and then assayed for GFP ﬂuorescence. Cotransfec-
tion of TetO-GFP-FoxM1-ΔN and CMV-rtTA plasmids in the presence
of Dox induced expression of the GFP-FoxM1-ΔN protein, which was
located in nuclei of transfected cells (Fig. 1C). No GFP ﬂuorescence
was observed in the absence of Dox. Furthermore, expression of GFP-
FoxM1-ΔN protein was induced by cotransfection of the TetO-GFP-
FoxM1-ΔN and CMV-tTA plasmids (Fig. 1C). The GFP-FoxM1-ΔN
protein was transcriptionally active as demonstrated by Dual
Luciferase Assay using 6xCDX2-LUC plasmid (Fig. 1C–D), a known
reporter for FoxM1 transcriptional activity (Ye et al., 1997).
To conditionally express FoxM1-ΔN mutant in the developing
respiratory epithelium, we generated TetO-GFP-FoxM1-ΔN trans-
genic mice. Three distinct transgenic mouse lines were established
and showed similar phenotypes. After breeding with SPC-rtTA mice,
the SPC-rtTA/TetO-GFP-FoxM1-ΔN double transgenic mouse line
(epFoxM1) was established and identiﬁed using PCR with primers
speciﬁc to human FoxM1 cDNA and the SPC-rtTA transgene (Fig. 2B).
The double transgenic mice permit expression of GFP-FoxM1-ΔN in
the respiratory epithelium after treatment with Dox (Fig. 2A).
FoxM1-ΔN caused epithelial hyperplasia during lung development
To examine the consequences of increased FoxM1 activity on lung
morphogenesis, expression of FoxM1-ΔN transgene was induced at
E7.5 and lungs harvested at different stages of development (Fig. 2C).
Total lung RNA was used to examine the expression levels of
transgenic FoxM1 mRNA by qRT-PCR. Human FoxM1 mRNA was
found in Dox-treated epFoxM1 double transgenic lungs at E15.5 and
P30 (Fig. 2E), but was undetectable in lungs of Dox-treated control
305I.-C. Wang et al. / Developmental Biology 347 (2010) 301–314(WT), single transgenic littermates and age-matched epFoxM1 lungs
without Dox treatment (Fig. 2E and data not shown).
When FoxM1-ΔN was induced from E7.5 to E15.5, lung size and
lobulation were normal. GFP ﬂuorescence conﬁrmed the induction
of the FoxM1-ΔN transgene by Dox (Fig. 2D). The presence of
FoxM1-ΔN transgenic protein in respiratory epithelial cells was also
conﬁrmed by immunohistochemistry with antibodies speciﬁc toFig. 2. Dox induced GFP-FoxM1-ΔN expression and caused epithelial hyperplasia in SPC-rtT
Dox-mediated induction of GFP-FoxM1-ΔN transgene in epFoxM1 lung epithelium. (B) PCR an
regiments of Dox treatment to induce GFP-FoxM1-ΔN transgene in mouse lung epitheliu
postnatal stages. (D) Dox treatment from E7.5 to E15.5 induced GFP ﬂuorescence in ep
Magniﬁcation is 100×. Parafﬁn sections of Dox-treated epFoxM1 lungs were stained with
(transgenic) FoxM1 or Ki-67 (dark brown nuclei). Slides were counterstained with Nuclear F
WT lungs. Epithelial hyperplasia was observed in epFoxM1 lungs (shown with arrows), w
(E) Real time RT-PCR analysis showed transgenic GFP-FoxM1-ΔN mRNA exclusively exp
numbers of Ki-67-positive epithelial cells in epFoxM1 lungs. Numbers of Ki-67-stained nucle
from epFoxM1 and control mice. A statistically signiﬁcant p valueb0.05 is shown with asterihuman FoxM1 protein (Fig. 2D) (this antibody does not cross-react
with endogenous mouse Foxm1 protein). FoxM1-ΔN induced
epithelial hyperplasia, characterized by the presence of pseudo-
stratiﬁed epithelium (normally a single columnar epithelium)
(Fig. 2D). Increased numbers of Ki-67 positive cells were consistent
with increased cellular proliferation in hyperplastic regions (Fig. 2D
and F). Numbers of epithelial cells expressing Sox2 and Sox9A/TetO-GFP-FoxM1-ΔN double transgenic (epFoxM1) lungs. (A) A schematic showing
alysis of transgenic embryos using primers depicted in Fig. 1C. (C) A schematic showing
m. Arrows indicate periods of Dox treatment and harvest times during prenatal and
FoxM1 lung epithelium. GFP ﬂuorescence was detected in nuclei of epithelial cells.
H&E or used for immunohistochemistry (IHC) with antibodies against either human
ast Red (red nuclei). FoxM1-ΔNwas detectable in Dox-treated epFoxM1 lungs but not in
hile a single layer of epithelial cells was detected in WT lungs. Magniﬁcation is 400×.
ressed in epFoxM1 lungs treated with Dox (E7.5–E15.5 and P3–P30). (F) Increased
i were counted in respiratory epithelium using twenty random 400× microscope ﬁelds
sk.
306 I.-C. Wang et al. / Developmental Biology 347 (2010) 301–314transcription factors were unchanged in epFoxM1 lungs (Supple-
mental Fig. 1A).
Increased FoxM1 activity impairs lung sacculation
Abnormal, dilated epithelial cysts were observed throughout the
peripheral lung in FoxM1-ΔN expressing mice when Dox was
provided from E7.5 to E18.5 or E7.5 to P1 (Fig. 3B and K). FoxM1-
ΔN protein was detected in the epithelial cells lining the abnormal
pulmonary cysts in epFoxM1 embryos (Fig. 3D) and was absent in
WT and single transgenic littermates (Fig. 3C and data not shown).Fig. 3. Sacculation defects in epFoxM1 lungs. Embryos and newbornmice were treated with D
and immunohistochemistry staining (IHC). (A–B) H&E staining showed sacculation defects i
FoxM1-ΔN was not detected in control (WT) lungs (C). (E–F) pro-SPC expression was detec
SPC (green). Erythrocytes showed autoﬂuorescence (yellow) in alveolar regions. CCSP
Immunoﬂuorescent staining showed that FoxM1-ΔN did not co-express with FoxJ1 in bronc
mice where it was co-expressed with CCSP (Q–T). FoxM1-ΔN did not co-localize with CCSPPro-SPC, a marker speciﬁc for type II epithelial cells, was absent in
epithelial cells expressing FoxM1-ΔN as demonstrated by immuno-
histochemistry (Fig. 3F) and co-localization experiments (Fig. 3H).
Interestingly, when Dox was given to mice from E13.5 until P1,
expression of FoxM1-ΔN transgene was dramatically reduced
(Fig. 4D), but it was still sufﬁcient to inhibit lung sacculation
(Fig. 4B). There was no signiﬁcant increase in apoptosis in FoxM1-ΔN
transgenic lungs as demonstrated by immunostaining with anti-
bodies against activated (cleaved) Caspase 3 (data not shown).
FoxM1-ΔN-expressing epithelial cells did not express pro-SPC
(Fig. 4H). Thus, increased FoxM1 activity impaired lung sacculationox from E7.5 to 18.5 (A–H) or E7.5 to P1 (I–X), and lungs were harvested for histological
n epFoxM1 lungs. (C–D) IHC showed FoxM1-ΔN protein in epithelium of epFoxM1 lungs.
ted in epFoxM1 and control lungs. (G–H) FoxM1-ΔN (red) did not co-localize with pro-
staining was detected in epFoxM1 and WT mouse lung airway epithelium (I–L).
hial epithelium (M–P). FoxM1-ΔN was found in pulmonary bronchiole (Br) of epFoxM1
in epithelial cells of abnormal pulmonary cysts (U–X).
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peripheral respiratory epithelial cells.
Since previous studies demonstrated that SPC-rtTA mice (line 1)
permit expression of rtTA in a subset of Clara cells during late
gestation (Perl et al., 2002; Tichelaar et al., 2000), expression of
FoxM1-ΔN transgene was examined in pulmonary airways. Trans-
genic protein was speciﬁcally detected in epFoxM1 airway epithelium
(Figs. 3O and 4G) but not in control airways (Figs. 3M and 4G). Clara
cell speciﬁc protein (CCSP) was present in both epFoxM1 and control
airways (Figs. 3I–L and 4E–F). FoxM1-ΔN transgene was found in
CCSP-positive Clara cells of large pulmonary airways in epFoxM1
embryos (Fig. 3S–T). In contrast, FoxM1-ΔN protein did not co-
localize with CCSP in distal epithelial cysts of epFoxM1 embryos
(Fig. 3W–X), indicating that FoxM1-ΔN-expressing epithelial cells
lining distal pulmonary cysts are not Clara cells. FoxM1-ΔN was not
expressed in ciliated cells as demonstrated by co-localization
experiments with FoxJ1 (Figs. 3M–P and 4G), a transcription factor
selectively expressed in ciliated cells (Blatt et al., 1999).
Increased FoxM1 activity during postnatal lung development caused
airway hyperplasia
To determine consequences of increased FoxM1 activity during
postnatal lung development, FoxM1-ΔN was induced from P3 to P30Fig. 4. Expression of FoxM1-ΔN in mouse lung epithelium from E13.5 to P1 caused saccu
characterized by thickening of mesenchyme and increased size of peripheral saccules. Epi
(B) but not in WT lungs (A). While transgenic FoxM1-ΔN protein was detected in epFoxM1 l
WT airways (E–F). Immunoﬂuorescent staining showed that FoxM1-ΔN did not co-localizein epFoxM1 mice (Fig. 5D), resulting in marked hyperplasia of the
airway epithelium (Fig. 5B), which was characterized by a pseudo-
stratiﬁed epithelium at sites normally lined by a single columnar
epithelium (Fig. 5A). TTF-1 and FoxA2 were expressed in the
hyperplastic airway regions induced by FoxM1-ΔN (Fig. 5F and H),
indicating the epithelial origin of hyperplastic cells. Moreover, the
cells of hyperplastic regions expressed CCSP but not pro-SPC,
indicating Clara cell hyperplasia (Fig. 5J and L). Co-localization
experiments demonstrated that transgenic FoxM1-ΔN protein was
co-expressed with TTF-1 (Fig. 6A) and CCSP (Fig. 6B), which is
consistent with ﬁndings in normal Clara cells. Although ciliated cells
were present in epFoxM1 airways as demonstrated by FoxJ1 staining
(Fig. 5N), FoxM1-ΔNwas not detected in ciliated cells (Fig. 6C). While
β-tubulin, a protein speciﬁc to cilia (Tichelaar et al., 1999), was
detected on apical surfaces of ciliated cells in control mice, β-tubulin
was detected in cytoplasm of ciliated cells located near the basal
lamina in epFoxM1 lungs (Fig. 6E).
To detect epithelial progenitor cells in bronchioalveolar duct
junctions, co-localization experiments with pro-SPC and CCSP anti-
bodies were performed. Although SPC+/CCSP+ cells were found in
bronchioalveolar duct junctions as well as bronchial epithelium of
epFoxM1 lungs (Suppl. Fig. 1C), there were no signiﬁcant differences
between their numbers in epFoxM1 and control lungs (Suppl. Fig. 1D).
Furthermore, to investigate the impact of FoxM1-ΔN expression onlation defects. H&E staining shows sacculation defects in epFoxM1 lungs, which were
thelial hyperplasia was observed in airway epithelium of Dox-treated epFoxM1 lungs
ungs (D), it was undetectable in WT lungs (C). CCSP was detected in both epFoxM1 and
with either FoxJ1 (G) or pro-SPC (H).
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sections using antibodies speciﬁc to F4/80 (macrophage marker), α-
smooth muscle actin (marker of smooth muscle cells) or Pecam-1
(endothelial marker). No differences were observed between epFoxM1
and control lungs (Suppl. Fig. 2B–C). Likewise, nodifferenceswere found
in numbers ofmajor cell types in peripheral blood (Suppl. Fig. 2A). These
results showed that FoxM1-ΔN expression did not inﬂuence pulmonary
stroma or numbers of immune cells in the peripheral blood.
Lineage-tracing experiments were performed to determine the
origin of the hyperplastic cells induced by FoxM1-ΔN. To
permanently label epithelial cells expressing FoxM1-ΔN, SPC-rtTA/
TetO-GFP-FoxM1-ΔN double transgenic mice (epFoxM1) were bred
with TetO-Cre/Rosa26-loxP-STOP-loxP-β-galactosidase reporter
mice (Rosa26R) to generate SPC-rtTA/TetO-GFP-FoxM1-ΔN/TetO-
Cre/Rosa26R quadruple transgenic mice. Mice without TetO-GFP-
FoxM1-ΔN transgene (SPC-rtTA/TetO-Cre/Rosa26R) were used as
controls. Dox was given from P3 until P30, simultaneously inducing
FoxM1-ΔN and Cre-mediated excision of the LoxP-STOP-LoxP
cassette from the ROSA26 locus. Thus, all cells expressing FoxM1-
ΔN transgene during this period were permanently labeled by β-
galactosidase. In controlmice, β-galactosidase activity was detected in
a subset of bronchial epithelial cells and type II epithelial cells of
alveolar regions, which is consistent with previous studies (Fig. 6D)
(Perl et al., 2002; Tichelaar et al., 2000). Hyperplastic regions induced
by FoxM1-ΔN showed β-galactosidase activity, indicating that airway
hyperplasia resulted from expansion of cells expressing the transgene.Fig. 5. Expression of FoxM1-ΔN during postnatal lung development causes airway hyperpl
stained with H&E (A–B) or used for immunohistochemical staining with antibodies against
(M–N). Arrows indicate hyperplastic epithelial regions in Dox-treated epFoxM1 bronchiolesThese results suggest a cell autonomous role for Foxm1 in the
hyperplastic process.
Gene expression proﬁle in epFoxM1 lungs
To identify potential FoxM1 target genes, expression of various
transcription factors and cell cycle regulatory genes in epFoxM1
lungs was examined by qRT-PCR. Expression of cell cycle regulatory
genes CDKN1A and c-Myc was increased in total lung RNA from
epFoxM1 mice (Fig. 7), which is consistent with changes in cellular
proliferation. Furthermore, expression of FoxM1-ΔN altered mRNA
levels of various Sox transcription factors. While Sox2, Sox4 and
Sox17 mRNAs were signiﬁcantly decreased in epFoxM1 lungs, Sox9
mRNA was increased (Fig. 7). Since previous studies demonstrated
that Sox2 and Sox17 are critical for epithelial morphogenesis in the
developing lung (Park et al., 2006; Tompkins et al., 2009), reduced
expression of these genes can contribute to airway defects seen in
epFoxM1 mice. Interestingly, mRNA levels of Foxa2, Foxa3, Foxf1,
Foxf2, Foxl1, Foxp1, Foxp2 and endogenous (mouse) Foxm1 were
not changed in epFoxM1 transgenic lungs, whereas a signiﬁcant
reduction of Foxj1 mRNA was found (Fig. 7), a result consistent with
reduced numbers of ciliated cells (Fig. 6C–E). No differences were
observed in mRNA levels of TTF1 transcription factor, Pecam-1 and
α-smooth muscle actin (Fig. 7). Altogether, these results indicate
that FoxM1-ΔN inﬂuences expression of pulmonary genes critical for
epithelial proliferation and lung morphogenesis.asia. epFoxM1 mice were treated with Dox from P3 to P30. Parafﬁn lung sections were
transgenic FoxM1 (C–D), TTF-1 (E–F), Foxa2 (G–H), CCSP (I–J), pro-SPC (K–L) or FoxJ1
(Br).
Fig. 6. FoxM1-ΔN is expressed in Clara cells of epFoxM1 mice. (A) Parafﬁn sections were stained with antibodies against transgenic FoxM1-ΔN (red) and mouse TTF-1 (green) and
then counterstained with DAPI (blue). Erythrocytes displayed yellow autoﬂuorescence in alveolar regions. (B) Parafﬁn sections were immunostained with antibodies against
FoxM1-ΔN (red) and CCSP (green) and then counterstained with DAPI (blue). FoxM1-ΔN co-localized with CCSP in epFoxM1 lungs. (C) FoxM1-ΔN (green) did not co-localize
with FoxJ1 (red). (D) β-Gal activity (blue) was detected in alveolar type II cells (green arrows) as well as hyperplastic airway regions of epFoxM1/TetO-Cre/Rosa26R lungs (black
arrow) after Dox treatment from P3 to P30. β-Galactosidase activity was also observed in type II cells and bronchial epithelial cells of control SPC-rtTA/TetO-Cre/Rosa26R lungs.
Slides were counterstained with nuclear fast red. (E) Lung sections from Dox-treated WT and epFoxM1 mice were immunostained with antibodies speciﬁc to β-tubulin (dark
brown). Slides were counterstained with nuclear fast red. Br, bronchiole.
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adult lung
When FoxM1-ΔN was expressed in adult mice from P30 to P120,
focal airway hyperplasia was observed (Fig. 8B). Papillary structures
were observed within airway lumens (Fig. 8B, D and data not shown).
Consistent with earlier ﬁndings, Ki-67 expression was observed in
airway regions expressing FoxM1-ΔN (Fig. 8D and F) and CCSP protein
(Fig. 8H). Single lung adenomas were observed in 2 out of 18 micewhen FoxM1-ΔN was expressed until 6 months of age (Fig. 8J). The
tumors were Ki-67 and phospho-Histone H3 positive (Fig. 8N and P),
but did not express FoxM1-ΔN or CCSP (Fig. 8L and data not shown).
FoxM1-ΔN cooperates with activated K-Ras to increase lung tumor
growth in vivo
To determine whether FoxM1-ΔN transgene increases a tumor
growth in the presence of activated (oncogenic) K-Ras. TetO-GFP-
Fig. 7. Expression of FoxM1-ΔN inﬂuenced mRNA levels of pulmonary genes. Lungs of mice treated with Dox from P3 to P30 were used to prepare total RNA. qRT-PCR shows
decreased mRNA levels of Sox2, Sox4, Sox17, and Foxj1 in epFoxM1 mice. CDKN1A, Sox9, and c-Myc mRNAs were increased. No changes were found in the expression of TTF1 and
various Fox genes. β-Actin mRNA was used for normalization. A p valueb0.05 is shown with asterisk (*).
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a known transgenic model of lung cancer (Fisher et al., 2001; Johnson
et al., 2001). Four-week-old SPC-rtTA/TetO-GFP-FoxM1-ΔN/TetO-K-
Ras triple transgenic mice (epFoxM1/epKras) were treated with Dox
for 20 weeks to induce simultaneous expression of FoxM1-ΔN and
activated K-Ras in respiratory epithelium. Consistent with previous
studies (Fisher et al., 2001; Johnson et al., 2001), expression of
activated K-Ras alone was sufﬁcient to induce formation of lung
adenocarcinomas (Fig. 9E–F), whereas expression of FoxM1-ΔN alone
did not cause lung tumors but resulted in formation of epithelial
hyperplasia (Fig. 9C–D). Tumor sizes in epFoxM1/ epKras mice were
signiﬁcantly increased compared to control epKras mice (Fig. 9I).
Transgenic FoxM1-ΔN protein was speciﬁcally found in epFoxM1/
epKras tumors by immunohistochemistry (Fig. 9G–H). These results
demonstrated that FoxM1-ΔN cooperates with activated K-Ras to
accelerate lung tumor growth in vivo.
Clara cell-speciﬁc expression of FoxM1-ΔN induced airway hyperplasia
To determine whether speciﬁc expression of activated FoxM1-ΔN
transgene in Clara cells induced airway hyperplasia, TetO-GFP-
FoxM1-ΔN transgenic mice were bred with CCSP-rtTA mice that
speciﬁcally express rtTA in Clara cells in a Dox-inducible manner
(Perl et al., 2002; Tichelaar et al., 2000). At 30 days of age, CCSP-rtTA/
TetO-GFP-FoxM1-ΔN double transgenic mice (CCSP-FoxM1) were
treated with Dox for 90 days (Fig. 10A). Expression of FoxM1-ΔN in
Clara cells induced airway hyperplasia at sites expressing the
transgene (Fig. 10E). Both CCSP and proliferation-speciﬁc Ki-67
were present in the lesions (Fig. 10G and I). Although lung tumors
were not observed in the CCSP-FoxM1 transgenic mice, speciﬁc
expression of FoxM1-ΔN in Clara cells was sufﬁcient to induce
airway hyperplasia.Discussion
Previous studies have demonstrated that Foxm1 is expressed in a
variety of respiratory cell types undergoing DNA replication and
mitosis (Kalin et al., 2008; Kalinichenko et al., 2003; Kim et al., 2005;
Wang et al., 2009). In this study, we found that Foxm1 expression in
the lung was dramatically reduced prior to birth, but was re-activated
during the early postnatal period. The observed pattern of Foxm1
expression is similar to that of cell proliferation, consistent with the
role of Foxm1 in the cell cycle. To address the stage-speciﬁc role of
Foxm1 in respiratory epithelium, we used a constitutively active
FoxM1-ΔNmutant to increase Foxm1 activity in epithelial cells under
control of Dox. We found that expression of FoxM1-ΔN transgene
during E7.5–E15.5 caused epithelial hyperplasia, indicating that
increased Foxm1 activity is sufﬁcient to accelerate cellular prolifer-
ation in undifferentiated respiratory epithelium. This ﬁnding is not
surprising, considering that Foxm1 directly activates transcription of
multiple cell cycle regulatory genes, including cyclins B1 and A2,
Cdc25B phosphotase, JNK1, PLK1 and Aurora B kinase (Costa, 2005;
Krupczak-Hollis et al., 2004; Laoukili et al., 2007; Wang et al., 2005,
2008a). We previously reported that a conditional deletion of the
Foxm1 gene from developing respiratory epithelium at E7.5–E14.5
(SPC-rtTA/TetO-Cre/Foxm1ﬂ/ﬂmice (Kalin et al., 2008)) caused severe
abnormalities in lung maturation and respiratory failure at birth,
however, no defects in epithelial proliferationwere found (Kalin et al.,
2008). Thus, Foxm1 appears to be dispensable for the cell cycle
progression in undifferentiated respiratory epithelium, suggesting
that other signaling pathways likely compensate for the loss of Foxm1
during lung development.
Previous studies demonstrated that a decrease in proliferation
rates occurs prior to formation of pulmonary saccules (Perl and
Whitsett, 1999). Severe sacculation defects were found in epFoxM1
Fig. 8. Expression of FoxM1-ΔN transgene in the adult lung causes hyperplasia of Clara cells. Histological staining and IHC of lungs isolated from epFoxM1 and WT mice after Dox
treatment for 3 months. (A–B) H&E staining displayed focal epithelial hyperplasia in epFoxM1 lungs (arrows). IHC with antibodies against FoxM1-ΔN (C–D), Ki-67 (E–F) and CCSP
(G–H) showed expression of these proteins in hyperplastic airway regions of Dox-treated epFoxM1mice (arrows). (I–P) Rare lung adenomas (Ad) were detected in epFoxM1 lungs.
These tumors were positive for Ki-67 (N) and pH3 (P), but negative for FoxM1-ΔN transgene (L).
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Similar phenotypes were found in transgenic mice expressing
activated K-Ras (Shaw et al., 2007; Tuveson et al., 2004), FGFR
(Hokuto et al., 2003), or FGF-7 (Tichelaar et al., 2000), all of which are
positive regulators of epithelial proliferation (Warburton et al., 2000).
Therefore, sacculation defects in epFoxM1 lungs may be a direct
consequence of increased proliferation of epithelial cells. Interestingly,
co-localization experiments demonstrated that cells expressing the
FoxM1-ΔN transgene lacked pro-SPC, a marker of mature type II
epithelial cells. These results suggest that increased Foxm1 activity
prevents differentiation of epithelial cells toward the type II cell
lineage. Impaired differentiation of type II cells resulted in sacculation
defects in transgenic mice over-expressing TTF1 (Wert et al., 2002),
Sox17 (Park et al., 2006) as well as in mice deﬁcient in Foxa2 (Wan
et al., 2004), NFAT (Dave et al., 2006), or β-catenin (Mucenski et al.,
2003). Therefore, abnormalities in the differentiation of type II cells
may contribute to the sacculation defects seen in epFoxM1 lungs.
Expression of FoxM1-ΔN transgene during the late gestation and
the postnatal period caused airway hyperplasia. We also found that
the majority of cells expressing FoxM1-ΔN transgene displayed
markers speciﬁc for Clara cells, demonstrating that airway hyperplasia
resulted from increased Clara cells proliferation. In contrast, the
transgene was not found in mature type II cells of the alveolar region.
These results are surprising, especially considering previous lineage-
tracing experiments demonstrating that SPC-rtTA (line 1) induced
Cre-mediated recombination in a majority of type II cells and in a
subset of airway Clara cells (Perl et al., 2002; Tichelaar et al., 2000).
Our results showed that transgenic FoxM1-ΔN expression acceleratedproliferation of Clara cells but did not inﬂuence proliferation of
mature type II cells. However, the mechanism underlying transgene
silencing in type II cells remains unclear. We hypothesized that
overexpression of activated FoxM1 protein could be toxic to mature
type II cells, nonetheless, in contrast to this hypothesis, there was no
cell apoptosis found in the epFoxM1 lungs. Furthermore, a robust β-gal
activity was observed in the alveolar region of epFoxM1/Rosa26R
lungs, suggesting that FoxM1-ΔN transgene was expressed and then
silenced in a majority of type II cells. It is possible that activated
FoxM1 promotes differentiation of epithelial progenitors towards the
Clara cell lineage and prevents differentiation of progenitors toward
type II cell lineage.
Increased Foxm1 levels have been found in numerous types of
human tumors (Laoukili et al., 2007), including non-small cell lung
cancers (Gialmanidis et al., 2009; Kim et al., 2006; Yang et al., 2009).
Our previous studies demonstrated that when the Foxm1ﬂ/ﬂ allele was
deleted in either all respiratory cell types or only in pulmonary
epithelial cells, the number and size of lung adenomas following
urethane exposure was reduced (Kim et al., 2006; Wang et al., 2009).
Over-expression of FoxM1 in all cell types using the Rosa 26 promoter
accelerated formation of lung adenomas induced by the tobacco
smoke carcinogen MCA (Wang et al., 2008b). Although these studies
indicate an important role of Foxm1 in lung carcinogenesis, it is not
clear whether an increase in Foxm1 activity alone in sufﬁcient to
cause lung tumors. In this study, we found that epFoxM1 mice
developed Clara cell hyperplasia after Dox treatment. Interestingly,
only 11% of epFoxM1mice developed single lung adenomas when Dox
was used for 6 months. Perhaps this result is not surprising since 13%
Fig. 9. FoxM1-ΔN cooperates with activated K-Ras to induce lung tumor growth in vivo. TetO-FoxM1-ΔNmice were bred with SPC-rtTA/TetO-K-Ras mice to generate SPC-rtTA/TetO-
FoxM1-ΔN/TetO-K-Ras triple transgenic mice (epFoxM1/epKras). Single transgenic littermates were used as controls. Mice were treated with Dox for 20 weeks. (A–H) Parafﬁn lung
sections were stained with antibodies speciﬁc for the FoxM1-ΔN transgene (brown nuclei) and counterstained with nuclear fast red (red nuclei). Expression of FoxM1-ΔN alone did
not cause lung tumors but resulted in formation of epithelial hyperplasia (arrows in D). (I) Tumor sizes in epFoxM1 epKras mice were signiﬁcantly increased compared to mice
expressing K-Ras alone. Tumor areas in lung sections were measured by Axiovision Rel software. Ten random lung sections were used to determine statistical signiﬁcance. A p
valueb0.05 is shown with asterisk (*).
Fig. 10. Clara cell hyperplasia in CCSP-rtTA/TetO-FoxM1-ΔN double transgenic (CCSP-FoxM1) mice. (A) A schematic showing Dox-inducible mouse model, which expresses
GFP-FoxM1-ΔN transgene under the control of CCSP promoter. (B–I) H&E and IHC staining of CCSP-FoxM1 and WT lungs after 3 months of Dox treatment (P30–P120). Hyperplastic
epithelial regions (arrows) were detected in CCSP-FoxM1 airways, which were positive for FoxM1-ΔN (D–E), CCSP (F–G) and Ki-67 (H–I).
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developed lung tumors by 14 months of age (Mahler et al., 1996).
Interestingly, we found that FoxM1-ΔN transgene accelerated a tumor
growth in the presence of activated (oncogenic) K-Ras. These results
suggest that FoxM1-ΔN cooperates with activated K-Ras to induce
lung tumor growth in vivo.
In summary, expression of activated Foxm1 transgene resulted in
epithelial hyperplasia and sacculation defects during lung formation in
late gestation. FoxM1-ΔN expression during the postnatal period
caused focal airway hyperplasia, increased proliferation of Clara cells
and altered expression of Sox transcription factors. FoxM1-ΔN
accelerated tumor growth induced by activated K-Ras. Precise
regulation of Foxm1 expression in respiratory epithelial cells is critical
for lung sacculation, proper development of airway epithelium, and
lung tumorigenesis.
Supplementarymaterials related to this article can be found online
at doi:10.1016/j.ydbio.2010.08.027.
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